1. Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies Introduction and Overview May 30 to June 4, 2005 Abuja, Nigeria

2. Priority Setting and Effectiveness
Prioritizing Programs of Care for People with HIV/AIDS
Potential Priority Populations for the Distribution of Antiretroviral Drugs
Avoiding the Pitfalls: Ways to Reduce Costs and Improve Effectiveness of HIV Control Programs

3. Intellectual Property Rights
IPR: What are they?
National Regulatory Situation – TRIPS compliant flexibilities for different countries (e.g., LDCs Developing)
Specific provisions affecting developing country members of WTO providing public health flexibilities (e.g, compulsory licensing, government use)

4. What determines drug prices?
Financing and Pricing
What determines drug prices?
Market segmentation, differential and equity pricing
Additional price determinants in retail markets
How can public purchasers bargain for low prices

5. Pharmaceutical Systems - Managing the Supply Side
Who does what?
What tasks need to be done?
Who is already carrying out these tasks?
Who can help in selection and quantification?
Who can help with regulatory issues, registration, IPRs and import?
Who can help with procurement, storage and distribution?

6. Product Selection & Quantification
Areas of Treatment
Highly Active Antiretroviral Therapy (HAART) for adults and adolescents
Treatment of opportunistic infections
Treatment of HIV infection in women of childbearing potential, or pregnant women
Treatment of HIV in children
Prevention of Mother-to-Child transmission
Post-exposure prophylaxis

7. Product Selection & Quantification
Essential Medicines for ARV Treatment
WHO publishes the authoritative list of essential medicines for HIV/AIDS, including a list of antiretrovirals (ARVs)
Medicines should be selected by a multidisciplinary team
Consult on a regular basis

8. Product Selection & Quantification
What quantities of drugs need to be bought?
There are several options available to order optimal quantities:
Track usage
Track usage and adjust the data for other sites
Estimate number of patient using the drugs and disease data

9. Quality Assurance
To introduce non-experts to pharmaceutical quality control and regulation
Drugs must be safe, effective and of consistent quality
Adherence to GMP and compliance with quality specifications are key

10. Procurement Assessing capacity
Commodities that support the HIV/AIDS program
Planning procurement
Registering products
Choosing procurement methods
Pooled procurement (national or regional)

11. Supply Chain Management
Storage
Inventory Control
LMIS

12. Rational Drug Use
Impact of RDU on other parts of the pharmaceutical system
Drug use as a management function
Factors influencing rational drug use
Irrational use of drugs

13. The Training Program How is the Training Program organized?
Training Modules
Summary
Background
Case Studies
Instructor and Participant Versions